Most viewed in the last 7 days from JAMA Health Forum: This economic evaluation found that although tirzepatide and semaglutide offered substantial long-term health benefits, they were not cost-effective at current net prices. https://ja.ma/4kSxCO6
JAMA Health Forum
医院和医疗保健
CHICAGO，IL 1,840 位关注者
An online OA health policy journal addressing health systems, reform, delivery, economics, more. Part of JAMA Network.
关于我们
JAMA Health Forum is published online weekly, every Friday, with timely news and commentary published throughout the week. The journal receives over 1 million online visits annually and more than 2.3 million article views and downloads. All research articles that are accepted for publication require payment of an article processing charge (APC) of $3000. Additional waivers and discounts on open access article processing charges are available for eligible authors from Hinari Core Offer countries. JAMA Health Forum is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications. The median time to first decision is 5 days, and 48 days with review. JAMA Health Forum follows the same peer review, editorial, and publishing standards of JAMA and the JAMA Network journals. The Journal Impact Factor is 11.5, one of the highest rankings among health care sciences and services journals. John Z. Ayanian, MD, MPP, the inaugural Director of the Institute for Healthcare Policy and Innovation at the University of Michigan, the Alice Hamilton Distinguished University Professor of Medicine and Healthcare Policy, Professor of Health Management and Policy, Professor of Public Policy, and a practicing general internist, is the founding editor in chief.
- 网站
-
https://jamanetwork.com/journals/jama-health-forum
JAMA Health Forum的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 201-500 人
- 总部
- CHICAGO，IL
- 创立
- 2019
- 领域
- Health Policy、Health Care、Health Systems和Health Care Reform
动态
-
This Viewpoint describes difficulties of quantifying health impacts of legal policies and outlines some steps that are key to creating scientifically credible legal data. https://ja.ma/4bCSGE5
-
-
An open-source LLM performed comparably to GPT-4 in generating differential diagnoses for complex cases, indicating that high-performing, locally-deployable custom models can enhance clinical decision support while ensuring data privacy and flexibility. https://ja.ma/4idjcWU
-
-
Lawrence Gostin joins JAMA Health Forum Editor in Chief Sandro Galea, MD, DrPH, for a conversation on the United States, the World Health Organization, and the Global Health Infrastructure. https://ja.ma/4kM8ubM
-
While tirzepatide and semaglutide offer significant long-term health benefits, this study's findings suggest that they are not cost-effective at current prices. https://ja.ma/4bGC12h
-
-
This Viewpoint describes difficulties of quantifying health impacts of legal policies and outlines some steps that are key to creating scientifically credible legal data. https://ja.ma/41vI19r
-
-
An open-source LLM performed comparably to GPT-4 in generating differential diagnoses for complex cases, indicating that high-performing, locally-deployable custom models can enhance clinical decision support while ensuring data privacy and flexibility. https://ja.ma/3R1fFPm
-
-
Lawrence Gostin joins JAMA Health Forum Editor in Chief Sandro Galea, MD, DrPH, for a conversation on the United States, the World Health Organization, and the Global Health Infrastructure. https://ja.ma/3DEbfuZ
-
While tirzepatide and semaglutide offer significant long-term health benefits, this study's findings suggest that they are not cost-effective at current prices. https://ja.ma/3DwhW1Y
-
-
This Special Communication considers how the universal adoption of molecular testing for hemoglobinopathy newborn screening can overcome current shortcomings. https://ja.ma/3XtHx2t
-